Evotec SE (EVO) Change in Cash (2009 - 2026)
Evotec SE's (EVO) quarterly Change in Cash came in at -$41.5 million in Q1 2026, down 119.32% year-over-year from $214.8 million in Q1 2025, and down 26.98% quarter-over-quarter from -$32.7 million in Q4 2025.
Analysis
Evotec SE (EVO) Change in Cash (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Change in Cash across 9 years of filings, most recently posting -$41.5 million for Q1 2026.
- In Q1 2026, Change in Cash fell 119.32% year-over-year to -$41.5 million; the TTM figure through Mar 2026 stood at -$187.2 million (up 40.94% YoY), while the FY2025 annual figure was $141.0 million, up 160.76% from the prior year.
- Change in Cash came in at -$41.5 million for Q1 2026 at Evotec SE, down from -$32.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $29.0 million in Q2 2023 to a low of -$238.8 million in Q3 2022.
- Average Change in Cash over 5 years is -$55.4 million, with a median of -$32.7 million recorded in 2025.
- Year-over-year, Change in Cash jumped 119.19% in 2023 and plunged 1245.86% in 2024.
- Over 5 years, Change in Cash stood at -$238.8 million in 2022, then surged by 112.14% to $29.0 million in 2023, then tumbled by 64.02% to $10.4 million in 2024, then plunged by 413.28% to -$32.7 million in 2025, then decreased by 26.98% to -$41.5 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were -$41.5 million in Q1 2026, -$32.7 million in Q4 2025, and -$101.6 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -38.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -149.99 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 928.39 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 42.38 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 21.10 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -16.65 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -514,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.71 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -41.49 Mn |
| Dec 31, 2025 | -32.67 Mn |
| Sep 30, 2025 | -101.63 Mn |
| Jun 30, 2025 | -11.42 Mn |
| Mar 31, 2025 | -18.92 Mn |
| Sep 30, 2024 | 10.43 Mn |
| Jun 30, 2024 | -216.18 Mn |
| Mar 31, 2024 | -92.29 Mn |
| Jun 30, 2023 | 28.98 Mn |
| Mar 31, 2023 | 8.05 Mn |
| Sep 30, 2022 | -238.76 Mn |
| Jun 30, 2022 | 27.04 Mn |
| Mar 31, 2022 | -41.97 Mn |
| Sep 30, 2021 | 57.89 Mn |
| Jun 30, 2021 | 83.11 Mn |
| Mar 31, 2021 | -31.50 Mn |
| Dec 31, 2019 | 201.08 Mn |
| Sep 30, 2010 | -19.35 Mn |
| Jun 30, 2010 | 221,714.64 |
| Mar 31, 2010 | -15,115.49 |